Novel drug target for triple-negative breast cancer discovered

[News]

Research led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studies, reports a combination of a novel small inhibitory molecule and an FDA-approved chemotherapy drug suppresses the growth of triple-negative breast cancer cells synergistically.

More... (https://www.news-medical.net/news/20221017/Novel-drug-target-for-triple-negative-breast-cancer-discovered.aspx)